Why the study?
TAVR-explant is rare but increasing with substantial clinical impact as TAVR expands into younger and lower-risk patients.
Providers should consider the potential for future TAVR-explant during the selection of an initial valve strategy, especially as TAVR expands into younger and lower-risk patients.
Supports caution in initial TAVR valve selection for younger patients; leaves open need for prospective explant outcome data.
TAVR-explant is rare but increasing, and its clinical impact is substantial. As the utilization of TAVR expands into younger and lower-risk patients, providers should consider the potential for future TAVR-explant during selection of an initial valve strategy.
No takes yet. Share an insight, caveat, or question.
Brescia et al. (2021) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: